INTRODUCTION
Blood cell development during embryogenesis is initiated within the mesodermal germ layer in a process that requires the basic helix-loop-helix (bHLH) transcription factor SCL/tal1. [1] [2] [3] However, the precise steps leading to commitment to blood cell fate are incompletely characterized. Intimate spatial and temporal development of the hematopoietic and endothelial cell lineages in the embryo, shared marker gene expression, and knockout mice with defects in both lineages have lead to the hypothesis of a common origin for blood and endothelium, the hemangioblast. [4] [5] [6] [7] [8] [9] [10] [11] [12] By definition, the hemangioblast is a common progenitor for primitive and/or definitive hematopoietic and endothelial cell lineages. However, the divergence of the lineages and the phenotype of the earliest precursors in each lineage are not fully defined.
In the mouse embryo, the commitment to hematopoiesis occurs within days 7-8.25 (E7-8.25) of embryonic development, during which time hematopoietic progenitors of both primitive and definitive hematopoietic lineage appear in the extraembryonic yolk sac and embryo proper. [13] [14] After a transient wave of primitive erythropoiesis in the yolk sac, definitive hematopoietic progenitors from the yolk sac (YS) and para-aortic splanchnopleura/aorta-gonad-mesonephos (PAS/AGM) region seed the fetal liver, which is the principal site of definitive hematopoiesis during fetal life. [15] [16] [17] During the fetal liver stage, hematopoietic stem cells acquire the capacity to engraft and reconstitute bone marrow, and thus support life-long hematopoiesis. The origin of hematopoietic stem cells (HSC) during development is a subject of controversy. However, it has been generally accepted that de novo hematopoiesis occurs in two independent sites, the extraembryonic yolk sac and intraembryonic PAS/AGM, and that cells originating from both locations only.
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can contribute to adult hematopoiesis when stimulated appropriately. The earliest site of detectable HSC activity in developing mouse embryo is the PAS /AGM region where adult reconstituting HSC can be found at E 10.5, before the fetal liver stage. [17] [18] [19] [20] [21] Although no adult bone marrow reconstituting stem cells are found in the yolk sac before fetal liver hematopoiesis, yolk sac cells can reconstitute multilineage, long-term hematopoiesis in conditioned newborn recipients. 22, 23 This has led to the hypothesis that yolk sac stem cells are immature and require an additional maturation step within fetal liver before bone marrow engraftment can be achieved. Yolk sac cells have been shown to acquire some adult BM reconstitution potential by co-culture on an AGM derived stromal cell line 24 or overexpression of HOXB4. 25 In recent years, model systems have been developed that permit the study of hematopoietic and endothelial commitment in vitro. 26-32. Murine embryonic stem (ES) cells grown in suspension culture without feeder cells and leukemia inhibitory factor spontaneously form cell aggregates called embryoid bodies (EBs) and differentiate into cell types representing all germ layers, including hematopoietic and endothelial cells. The
EBs form cystic structures resembling yolk sac blood islands where the first steps of hematopoietic development occur in very similar fashion to that in the mouse embryo.
Furthermore, in vitro differentiation of ES cells affords study of gene targeted cells without confounding embryonic lethality of the developing mouse. In spite of the close similarity of hematopoietic development in the EBs to hematopoiesis in vivo, the validity of this model system has been questioned due to a failure in demonstrating the presence of authentic hematopoietic stem cells. However, recent work shows that EB derived 
MATERIALS AND METHODS

Culture and differentiation of ES cells
Wild type (J1 and CJ7), SCL -/-(J1) 34 
Methylcellulose colony assays
EBs were harvested at specific time points for plating into blast cell colony assay (d 3.25- colonies were picked at 4 days of methylcellulose culture and plated into growth factor reduced matrigel (Becton Dickinson) coated dishes in IMDM, 10% FCS, 10% horse serum, 5 ng/ml VEGF, 10 ng/ml IGF-1, 10 ng/ml bFGF, 2U/ml Epo, 50 ng/ml SCF, 10ng/ml IL3 (R&D Systems) and endothelial cell growth supplement (Collaborative Biomedical Products, Becton Dickinson).
For analysis of hematopoietic precursors, the methylcellulose mix was supplemented with hematopoietic growth factors 2U/ml Epo, 100 ng/ml mSCF, 1 ng/ml mIL3, 5 ng/ml mIL6, 5 ng/ml mTpo, 30 ng/ml h-G-CSF, 3 ng/ml mGM-CSF, 5 ng/ml IL11 and 5 ng/ml mM-CSF. Hematopoietic colonies were scored individually by microscopy and May Grunwald Giemsa (MGG) staining at 5-8 days of differentiation. 
Endothelial cell cultures
Analysis of mouse embryos
To analyze embryonic and fetal hematopoietic development in mice, inbred (C57Bl6) and outbred (Swiss webster) mice were time-mated and embryos were collected at E 8.5, 9.5 and 10.5 for studies of yolk sac hematopoiesis and at E 12.5 or 14.5 for fetal liver Whole-mount immunohistochemistry for E8.5 and E9.5 embryos using anti-CD41 antibody (Pharmingen) were performed essentially as described. 36 Peroxidase staining was used for antibody detection. FITC conjugated anti-CD41 antibody was used to stain 10µ cryosections of dissected E9.5 yolk sac that had been fixed with 4%
paraformaldehyde.
only.
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RESULTS
Kinetics of expression of hematopoietic and endothelial surface markers in wild type and transcription factor mutant EBs.
To analyze the commitment of mesoderm to hematopoietic and endothelial cell lineages, wild type and transcription factor mutant ES cells were examined during differentiation in vitro. SCL -/-ES cells were used as a negative control for hematopoietic development, as previous studies have shown complete absence of hematopoietic activity in SCL -/-EBs. 3, 34, 35 EBs were harvested at specific times and subjected to FACS analysis. Table 1 demonstrates similar kinetics of expression of the early mesoderm/hemangioblast markers c-kit, Flk1 and 4integrin (CD49d) (Fig 2) . Other hematopoietic markers were present in lower frequencies (Mac1 42+3%, Gr1 41+5%, Ter119 6+1.4%, CD45 23+3% c-kit 25+9%). A subfraction of cells in the blast colonies also expressed the endothelial markers MECA32 (58+6%) and VEcadherin (42+19%) and endothelial/hematopoietic marker CD34 (34+5%) (Fig 2C) .
Developmental potential of CD41 + and CD41 -EB fractions
As CD41 was the first marker absent in SCL -/-EBs and the most frequently expressed blood specific marker present in SCL dependent blast colonies, wild type EBs were fractionated based on CD41 expression and the developmental potential of CD41 + and CD41 -populations were individually assessed. EBs were differentiated for 5-7 days, trypsinized into single cell suspensions, and sorted for surface expression of CD41.
Expression of CD41 was present on 2-4% of cells at day 5, and increased to 5-30% at days 6 and 7. Morphologically, EB-derived CD41 + cells comprised a rather homogenous, only.
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blast-like population (Fig 3A) . In contrast, CD41
-cells were quite heterogeneous in appearance ( Fig 3B) .
To assay hematopoietic potential, sorted cells were plated into methylcellulose cultures supplemented with a combination of hematopoietic growth factors. At all times, definitive hematopoietic activity was highly enriched in the CD41 + fraction (Fig 3C) , whereas the CD41 -fraction yielded no growth or secondary EBs consisting of tightly packed cells (Fig 3 D) . At day 5, primitive erythroid elements were observed from both 
Expression of CD41 in the mouse embryo
To correlate in vitro ES cell differentiation with embryonic hematopoiesis in vivo, CD41 expression was studied in time mated mouse embryos. Whole mount staining demonstrated expression of CD41 in yolk sac blood islands at E 8.5 and 9.5 (not shown and Fig 4) in similar locations to GATA-1 (not shown). At E 9.5 CD41 expression was detected in the vitelline and umbilical vessels; however, the endothelial cell network that stains with PECAM (not shown) in the embryo proper did not express detectable CD41.
Staining with FITC conjugated anti-CD41 antibody demonstrates the presence of individual CD41 + cells inside yolk sac blood islands at E 9.5 ( Fig 4B) and occasionally inside the vessels in the embryo proper (not shown); Endothelial cells in blood islands at E 9.5 did not express detectable CD41.
FACS analysis of hematopoietic organs revealed abundant surface expression of CD41 (5-25%) in the yolk sac at E 8.5, 9.5 and 10.5. Likewise, some CD41 expression was detectable in the AGM region at d10.5, and in E12.5 and 14.5 fetal liver, indicating localization of CD41 expression into sites of hematopoietic activity in the mouse embryo and the fetus (Fig. 5A and not shown) .
Definition of the surface phenotype of hematopoietic progenitors during murine ontogeny
Analysis of the kinetics of surface marker expression in the EBs and yolk sac demonstrated that CD45 expression is first detectable in a subpopulation of CD41 positive cells (Fig. 1C and 5A ). To define whether hematopoietic progenitor activity resided only in the CD45 + fraction of CD41 + cells, cells were sorted by CD45 and CD41
For (Table 2) .
For 
Expression of CD41 appears after the hemangioblast stage and development of primitive hematopoietic and endothelial cell lineages
The earliest hematopoietic activity detected in vitro from the EBs is derived from Flk1 + cells which in response to VEGF give rise to blast cell colonies that exhibit definitive and primitive hematopoietic and endothelial cell potential filling the formal criteria for the only.
19.
hemangioblast. As most of the daughter cells in blast cell colonies also express CD41, we considered the possibility that CD41 might be a marker for the hemangioblast. However, expression of CD41 in the EBs appears after the detection of hemangioblast and primitive erythroid activity (d3.25-3.5 and 4, respectively) 31 and endothelial marker expression. and myeloid colonies. These data suggest that in vitro in EBs and in vivo in the yolk sac, expression of CD41 spans the development from a Flk1+ hemangioblast to definitive hematopoietic progenitors that later express CD45 (Fig. 7) . One obvious caveat is that our data are derived from progenitor assays, whereas the development and surface phenotype of hematopoietic stem cells (HSC) remains to be studied by in vivo assays.
Nevertheless, newborn reconstituting stem cells within the yolk sac have been shown to express c-kit and CD34, 23 markers that we found to be coexpressed with CD41 in the yolk sac and in EBs. During mouse development, the earliest adult repopulating HSCs have been proposed to arise from the walls of dorsal aorta in the AGM region and vitelline and umbilical vessels. [17] [18] [19] [20] [21] Whole mount staining and FACS analyses showed some expression of CD41 in the vitelline and umbilical vessels and in the AGM region.
In situ immunohistochemistry analysis of CD41 expression during mouse embryonic development demonstrates that expression of CD41 is present in hematopoetic clusters in the walls of dorsal aorta, umbilical artery and in the lumen of yolk sac blood islands.
44
The developmental potential of the early CD41 + cells in the mouse remains to be only.
CD45
-HSC in E 10.5 AGM and E 12.5 fetal liver, a phenomenon that was accentuated by runx1/AML1 haploinsufficiency. 45 Whether these early HSCs express CD41 remains to be studied further.
Expression of CD41 is downregulated in hematopoietic progenitors by the fetal liver stage
The fetal liver serves as the site of definitive hematopoietic development and HSC maturation from E11.5 to early postnatal life. Abundant adult reconstituting HSCs are found in the fetal liver from E 12.5 17, 20, 46 We extended the sorting analysis with CD45
and CD41 expression to E 14.5 FL and performed colony forming unit assays from sorted subpopulations. In contrast to embryoid bodies and yolk sac in which a significant fraction of hematopoietic progenitors do not express CD45, all hematopoietic activity was detected within the CD45 + population in E14.5 fetal liver. When subfractionated with CD41 expression, the majority of CFU-C including mixed colonies as well as CFU-S8
were found in the CD45 single positive population (Mikkola and Orkin, unpublished data). Further long term transplantation studies are required to determine whether CD41 is expressed in adult bone marrow reconstituting stem cells in the fetal liver.
In humans, CD41 cells in cord blood exhibit myeloid and lymphoid potential as well as LTC-IC (long-term culture initiating cell) and NOD-SCID (non-obese diabetic/severe combined immunodeficient) repopulating activity. 47 In the avian model, CD41 + CD45 + cells also develop from intraaortic clusters, the sites of HSC emergence, and in embryonic and adult BM exhibit multilineage potential. 48 These data suggest that only.
For
across species, CD41 expression is not restricted to the megakaryocyte lineage. At the time of initiation of definitive hematopoiesis, CD41 is expressed in the vast majority of definitive hematopoietic progenitors whereas later in development its expression is restricted to a subset of progenitors with more restricted developmental potential. [47] [48] [49] Differential expression of hematopoietic surface markers during ontogeny has been described for other surface markers, such as CD34, Mac1 and AA4. 20, 50, 51 The functional significance of such variation in relation to specific microenvironment influences has yet to be fully explored, although CD34 positivity appears to correlate with stem cell activation. 52 Thus far, no markers that are predominantly associated with the yolk sac stage have been identified. Whether down-regulation of CD41 is involved in the maturation of adult bone marrow reconstituting stem cells remains to be studied by further in vivo assays.
Role of CD41 in hematopoiesis during ontogeny is unknown
We have identified CD41 as a commitment marker for hematopoiesis between Flk1 
The data consists of mean + SEM from three independent experiments. * indicates that majority of the colonies were primitive erythroid colonies only.
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